{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-006495","form_type":"8-K","ticker":"XENE","cik":"0001582313","company_name":"Xenon Pharmaceuticals Inc.","filed_at":"2025-01-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.071230+00:00","generated_at":"2026-05-27T23:12:46.210919+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Xenon Pharmaceuticals CCO Christopher Von Seggern departs; consulting agreement through May 2025","bullets":["Christopher Von Seggern ceased as Chief Commercial Officer on January 17, 2025.","Separation Agreement provides severance per 2020 offer letter and 2024 annual bonus.","Consulting Agreement through May 1, 2025; equity awards continue vesting until then.","No replacement named for the CCO role."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-006495","json":"https://secwatch.observer/filing/0000950170-25-006495.json","markdown":"https://secwatch.observer/filing/0000950170-25-006495.md","text":"https://secwatch.observer/filing/0000950170-25-006495.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1582313/000095017025006495/0000950170-25-006495-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1582313/000095017025006495/xene-20250117.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T23:12:46.210919+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"540d0fc501","claim":"Christopher Von Seggern departed as Chief Commercial Officer at Xenon Pharmaceuticals Inc..","evidence_excerpt":"On January 17, 2025, Christopher Von Seggern ceased to be the Chief Commercial Officer of Xenon Pharmaceuticals Inc. (the “Company”) and departed the Company as of such date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1582313/000095017025006495/0000950170-25-006495-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Chief Commercial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}